» Authors » Santanu Dasgupta

Santanu Dasgupta

Explore the profile of Santanu Dasgupta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 143
Citations 3315
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Galappaththi S, Smith K, Alsatari E, Hunter R, Dyess D, Turbat-Herrera E, et al.
Int J Mol Sci . 2024 Dec; 25(23). PMID: 39684874
Breast cancer is a significant health challenge worldwide and is the most frequently diagnosed cancer among women globally. This review provides a comprehensive overview of breast cancer biology, genomics, and...
2.
Pritam P, Manjre S, Shukla M, Srivastava M, Prasannan C, Jaiswal D, et al.
Metabolomics . 2024 Sep; 20(5):107. PMID: 39306586
Introduction: This study focuses on metabolic profiling of a robust marine green algal strain Picochlorum sp. MCC39 that exhibits resilient growth under diverse outdoor open pond conditions. Given its potential...
3.
Khan M, Acharya S, Anand S, Sameeta F, Pramanik P, Keel C, et al.
iScience . 2023 Dec; 26(12):108487. PMID: 38089573
MYB acts as a potentiator of aggressiveness and castration resistance in prostate cancer (PCa) through aberrant activation of androgen receptor (AR) signaling. Since Black men experience higher PCa incidence and...
4.
Dhokane D, Shaikh A, Yadav A, Giri N, Bandyopadhyay A, Dasgupta S, et al.
Front Bioeng Biotechnol . 2023 Nov; 11:1267826. PMID: 37965048
Microalgae, as photosynthetic organisms, have the potential to produce biomolecules for use in food, feed, cosmetics, nutraceuticals, fuel, and other applications. Faster growth rates and higher protein and lipid content...
5.
Haastrup M, Vikramdeo K, Anand S, Khan M, Carter J, Singh S, et al.
Mol Cancer Res . 2023 Oct; 22(2):197-208. PMID: 37878010
Implications: TOMM22 bears potential for early diagnostic/prognostic biomarker development and therapeutic targeting for better management of patients with pancreatic cancer.
6.
Vikramdeo K, Anand S, Sudan S, Pramanik P, Singh S, Godwin A, et al.
FASEB Bioadv . 2023 Oct; 5(10):412-426. PMID: 37810173
Early detection and recurrence prediction are challenging in triple-negative breast cancer (TNBC) patients. We aimed to develop mitochondrial DNA (mtDNA)-based liquid biomarkers to improve TNBC management. Mitochondrial genome (MG) enrichment...
7.
Hertweck K, Vikramdeo K, Galeas J, Marbut S, Pramanik P, Yunus F, et al.
FASEB J . 2023 Jun; 37(7):e23018. PMID: 37310411
Early detection, accurate monitoring, and therapeutics are major problems in non-small-cell lung cancer (NSCLC) patients. We identified genomic copy number variation of a unique panel of 40 mitochondria-targeted genes in...
8.
Ibodeng G, Uche I, Mokua R, Galo M, Odigwe B, Galeas J, et al.
Ann Transl Med . 2023 Apr; 11(6):261. PMID: 37082671
Background And Objective: The global impact of cancer and cancer-related deaths has been a huge challenge and continues to be a setback in the health sector and beyond even in...
9.
Dhokane D, Kancharla N, Savarimuthu A, Bhadra B, Bandyopadhyay A, Dasgupta S
Methods Mol Biol . 2023 Mar; 2653:207-217. PMID: 36995629
Genome editing technologies have provided opportunities to manipulate literally any genomic location, opening new avenues for reverse genetics-based improvements. Among them, CRISPR/Cas9 is the most versatile tool for genome editing...
10.
Vikramdeo K, Sharma A, Anand S, Sudan S, Singh S, Singh A, et al.
Int J Mol Sci . 2023 Mar; 24(5). PMID: 36901912
Prostate cancer (PCa) affects millions of men worldwide and is a major cause of cancer-related mortality. Race-associated PCa health disparities are also common and are of both social and clinical...